Gregg Williams, who serves as both a director and a ten percent owner of Vivani Medical, Inc. (NASDAQ:VANI), executed a substantial purchase of the company’s common stock in May 2026. Specifically, he acquired 1,587,301 shares of VANI's common equity on May 15, 2026.
This transaction was completed at an agreed price of $1.26 per share, resulting in a total expenditure of approximately $1,999,999. The acquisition involved a private sale structure, as documented within a Share Purchase Agreement dated August 11, 2025.
It is noteworthy that the purchase price of $1.26 per share aligned precisely with the last reported closing price for Vivani Medical's common stock on Nasdaq, which occurred on August 10, 2025, just one day prior to the agreement date. This suggests a careful timing relative to recent market pricing.
Current Market Context and Valuation Metrics
The insider purchase takes place against a backdrop of varied market signals for Vivani Medical. Currently, VANI trades at $1.14 per share, assigning the company an overall market capitalization valued at $98.3 million. Despite this recent director activity, third-party analysis provides mixed views on the stock's valuation.
According to InvestingPro analysis, the current stock levels suggest that Vivani Medical may be overvalued. Furthermore, the platform’s Financial Health score rates the company as